http://www.precigen.com
Precigen, Inc. Company Intro
Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies.
Industry
Healthcare
Precigen, Inc. Headquaters
20374 Seneca Meadows Parkway
Germantown,20876
United States
Precigen, Inc. Share price
16 Apr 2021 02:24 GMT
$7.27
0.0 (0.0 %)
Precigen, Inc. Market cap
$1.608 B
WMC RANKING
2021
Precigen, Inc. # 74
BiotechnologyLatest Precigen, Inc. News
03 Mar 2021
Time To Worry? Analysts Are Downgrading Their Precigen ...
Analysts Are Downgrading Their Precigen, Inc. (NASDAQ:PGEN) Outlook. By: Simply Wall St. Published: March 03, 2021.
03 Mar 2021
Precigen, Inc. (NASDAQ:PGEN) Forecast to gain 37.88% to hit Consensus price target
Precigen, Inc. (NASDAQ:PGEN) has a beta value of 2.39 and has seen 1,899,555 shares traded in the last trading session. The company, currently valued at ...
WMC Market Score
WMC Market to Revenue Score
Precigen, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Precigen, Inc. | USD | $90,722 | $202,723 | $-322,324 | $14,950B | 74 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $515,480B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,205,683 | $2,599,993 | $2,711,647 | $561,980B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,069,900 | $2,656,500 | $603,400 | $341,400B | 3 |
| Incyte Corporation | USD | $2,229,409 | $1,622,822 | $446,906 | $180,730B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Precigen, Inc. Social Followers vs Top 4 Industry Competitors
Precigen, Inc. Post vs Top 4 Industry Competitors
Precigen, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Precigen, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Precigen, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Precigen, Inc. | 0.98 | 1.06 | 0.09 | 0 | 0 | 0 | 0.44 |
| Regeneron Pharmaceuticals, Inc. | 100 | 23.95 | 9.71 | 100 | 0 | 0 | 51.39 |
| Vertex Pharmaceuticals Incorporated | 67.14 | 35.09 | 2.77 | 86 | 0 | 0 | 47.55 |
| Alexion Pharmaceuticals, Inc. | 65.67 | 100 | 100 | 60 | 0 | 0 | 100 |
| Incyte Corporation | 24.12 | 4.95 | 0.25 | 2 | 0 | 0 | 2.93 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
